Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_assertion description "[Cyclosporin A (CsA) is an immunosuppressant that inhibits protein phosphatase 2B (PP2B/calcineurin) and is associated with hyperlipidemia, decreased cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1), and increased risk of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_assertion evidence source_evidence_literature NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_assertion SIO_000772 19589783 NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_assertion wasDerivedFrom befree-20150227 NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_assertion wasGeneratedBy ECO_0000203 NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP218230.RAW89d7vX-EK6o7TXOBFPvZIo1aM8QF18spk1PClQlfkc130_provenance.